Highlights
Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer
BIO: Diversity, Digital and Partnerships Combine to Push Forward New Ideas in Healthcare
Innovation and collaboration were at the heart of the exchanges between the BIO attendees from around the globe
Mobilizing for the Planet
Insider Stories
Discover the Faces and the Stories Behind My Child Matters
A Chance for Every Child to Beat Cancer
Newsflow
Bringing New Hope to People Living with Multiple Sclerosis
Learn about Sanofi’s commitment to multiple sclerosis
Dengvaxia® vaccine approved for prevention of dengue in Europe
The European Commission has granted marketing authorization for Dengvaxia®, Sanofi’s dengue vaccine
.jpg?h=1614&la=en&w=1174&hash=3963D72C98F2C4B491F4FED5DFE2B969E487D1B6)
-
Press releases2019-06-26MMMM DD YYYYSanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis